Wenzhou People's Hospital Gynecotokology, Wenzhou, China.
Shanghai TCM-Integarted Hospitalgynecotokology, Shanghai, China.
J Clin Lab Anal. 2020 Jul;34(7):e23257. doi: 10.1002/jcla.23257. Epub 2020 Feb 26.
To investigate the correlation between hTREC and human papillomavirus (HPV) load and cervical intraepithelial neoplasia (CIN) grade II/III lesions and cervical cancer.
A total of 135 patients with cervical lesions of different degrees admitted to our hospital from January 2016 to February 2017 were selected, including CIN I/III 65 cases, grade III 39 cases, and cervical cancer 31 cases. The expression of hTERC gene was detected by fluorescence in situ hybridization (FISH) in three groups, and the HPV load was detected by second-generation hybridization capture (HC II) method, and its relationship with cervical lesion grade was analyzed. Department.
The positive expression rate of hTERC gene amplification was cervical cancer > CIN I/II lesion > CIN III lesion; the positive expression rate of HPV was cervical cancer > CIN I/II lesion > CIN III lesion. After treatment, the positive rate of hTERC gene amplification and HPV expression decreased significantly within 1 year (P < .05). Spearman's analysis showed that the degree of cervical lesion was positively correlated with hTREC and HPV load (P < .05).
hTREC and HPV are closely related to the occurrence and development of cervical precancerous lesions and cervical cancer. The abnormal amplification of hTERC gene increases with the grade of cervical lesions. Both of them can be used as auxiliary indicators for early screening, treatment, and prognosis of cervical cancer.
探讨人类端粒酶反转录酶基因(hTREC)与人乳头瘤病毒(HPV)载量与宫颈上皮内瘤变(CIN)Ⅱ/Ⅲ级病变及宫颈癌的相关性。
选取 2016 年 1 月至 2017 年 2 月我院收治的不同程度宫颈病变患者 135 例,包括 CINⅠ/Ⅲ级 65 例、Ⅲ级 39 例、宫颈癌 31 例。三组患者均采用荧光原位杂交(FISH)法检测 hTERC 基因表达,采用第二代杂交捕获(HC II)法检测 HPV 载量,并分析其与宫颈病变程度的关系。
hTERC 基因扩增阳性表达率依次为宫颈癌> CINⅠ/Ⅱ级病变>CINⅢ级病变;HPV 阳性表达率依次为宫颈癌>CINⅠ/Ⅱ级病变>CINⅢ级病变。治疗后 1 年内 hTERC 基因扩增及 HPV 表达阳性率均显著下降(P<0.05)。Spearman 分析显示,宫颈病变程度与 hTREC 及 HPV 载量呈正相关(P<0.05)。
hTREC 与 HPV 与宫颈癌前病变及宫颈癌的发生发展密切相关,hTERC 基因异常扩增随宫颈病变程度增加而增加,两者均可作为宫颈癌早期筛查、治疗及预后的辅助指标。